Photo of Phil Raess, M.D., Ph.D.

Phil Raess M.D., Ph.D.

Areas of interest

  • Clinical interests: Molecular pathology, hematopathology, and digital pathology
  • Research interests: The pathogenesis of various types of lymphoma, the effect of molecular events on tumor phenotype and prognosis, and development of novel diagnostic approaches for challenging hematopathology cases.

Education

  • B.S., Indiana University, Bloomington Indiana 2001
  • M.D., Ph.D., University of Wisconsin, Madison Wisconsin 2009
  • Residency:

    • Anatomic and Clinical Pathology, Hospital of the University of Pennsylvania, 2009-2013
  • Fellowship:

    • Surgical Pathology, Oregon Health & Science University, Portland, Oregon, 2013-2014
    • Hematopathology, Oregon Health & Science University, Portland, Oregon, 2014-2015
  • Certifications:

    • Anatomic and Clinical Pathology (American Board of Pathology), 2013
    • Hematopathology (American Board of Pathology), 2015

Publications

Selected publications

  • Select publications (link to PubMed listing below) 

  • MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes. Raess PW, Moore SR, Cascio MJ, Dunlap J, Fan G, Gatter K, Olson SB, Braziel RM. Leukemia & Lymphoma. 2018 Jun. PMID: 28868942.

  • Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential. Raess PW, Cascio MJ, Fan G, Press R, Druker BJ, Brewer D, Spurgeon SE. American Journal of Hematology.  2017 Jan. PMID: 27761930 

  • BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A. Blood. 2013 Oct 24. PMID: 24159168

Publications

  • "Overlapping Morphologic and Immunohistochemical Features of Hashimoto Thyroiditis and IgG4-Related Thyroid Disease" Endocrine Pathology April 22 2015
  • "Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia" British Journal of Haematology  2016
  • "Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential" American Journal of Hematology January 1 2017
  • "Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent" Journal of Hematology and Oncology  2016
  • "MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes" Leukemia and Lymphoma September 5 2017
  • "Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma" Leukemia and Lymphoma December 4 2017
  • "Retroperitoneal Leydig cell tumor recurrence presenting 14 years after orchiectomy" Canadian Journal of Urology February 1 2018
  • "A Missing Link" American Journal of Medicine January 1 2019
  • "Tracheobronchopathia osteochondroplastica presenting as a single dominant tracheal mass" Annals of Diagnostic Pathology December 1 2011
  • "BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia." Blood January 1 2013
  • "Cholecystokinin is up-regulated in obese mouse islets and expands β-cell mass by increasing β-cell survival" Endocrinology August 1 2010
  • "Catalytic reduction of 1-iodooctane by nickel(I) salen electrogenerated at carbon cathodes in dimethylformamide" Journal of Electroanalytical Chemistry May 1 2007
  • "α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors" American Journal of Surgical Pathology October 1 2012
  • "Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus" Nature Genetics June 1 2006
  • "Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK" Molecular Endocrinology February 1 2010
  • "Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters" American Journal of Hematology January 1 2014
  • "Overexpression of pre-pro-cholecystokinin stimulates β-cell proliferation in mouse and human islets with retention of islet function (Molecular Endocrinology (2008) 22, (2716-2728))" Molecular Endocrinology February 1 2010
  • "Image segmentation with implicit color standardization using cascaded EM"  August 15 2012
  • "Nipple leiomyoma" Journal of Cutaneous Pathology January 1 2019
  • "The role of molecular pathology in the diagnosis of cutaneous lymphomas" Pathology Research International December 26 2012
  • "Choline transporter immunohistochemistry" Pediatric and Developmental Pathology January 1 2017
  • "Overexpression of pre-pro-cholecystokinin stimulates β-cell proliferation in mouse and human islets with retention of islet function" Molecular Endocrinology December 1 2008
  • "Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management" Surgery for Obesity and Related Diseases September 1 2015
  • "Myelodysplastic/myeloproliferative neoplasms" Atlas of Genetics and Cytogenetics in Oncology and Haematology January 1 2018
  • "The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML" American Journal of Hematology August 1 2019
  • "Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid" Head and Neck Pathology January 1 2019
  • "CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma" Histopathology January 1 2019

Additional information

Edit profile